1311 |
Pragmatic Antithrombotic Strategies According to Bleeding and Ischemic Risk |
Duk-Woo Park |
Apr. 08. 22 |
1310 |
Escalation Antithrombotic Strategy: When and How? |
Davide Capodanno |
Apr. 08. 22 |
1309 |
Ischemic and Bleeding Risk Prediction After ACS and PCI |
Sunil Rao |
Apr. 08. 22 |
1308 |
Optimal DAPT Duration for PCI Patients at High Beeding Risk |
Roxana Mehran |
Apr. 08. 22 |
1307 |
Best Stent and Best Antithrombotic Strategy in High Bleeding Risk Patients: MASTER-DAPT, ONYX-ONE, LEADER-FREE and Others |
Marco Valgimigli |
Apr. 08. 22 |
1306 |
Imaging Based Coronary Physiology in the Clinical Practice: CTFFR and AngioFFR |
Bon-Kwon Koo |
Apr. 08. 22 |
1305 |
The Basics of Coronary Physiology Measurement: FFR, iFR and other NHPRs |
Jung-Min Ahn |
Apr. 08. 22 |
1304 |
When and How to Use Intracoronary Imaging in My Cath Lab |
Do-Yoon Kang |
Apr. 08. 22 |
1303 |
Practical Interpretation of Intracoronary Imaging for PCI |
Ziad A. Ali |
Apr. 08. 22 |
1302 |
Vulnerable Plaque Research |
Ik-Kyung Jang |
Apr. 08. 22 |